Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: The WISTERIA trial protocol

doi:10.1136/bmjopen-2019-033009

Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: The WISTERIA trial protocol

Research output: Contribution to journal › Article › peer-review

Original language	English
Article number	e033009
Journal	BMJ Open
Volume	10
Issue number	3
DOIs	https://doi.org/10.1136/bmjopen-2019-033009
Publication status	Published - Mar 16 2020
Externally published	Yes

ASJC Scopus Subject Areas

General Medicine

Keywords

TITE-CRM
chemoradiation
head and neck squamous cell carcinoma
wee1 inhibitor
window of opportunity study
wisteria

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1136/bmjopen-2019-033009

Fingerprint

Dive into the research topics of 'Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: The WISTERIA trial protocol'. Together they form a unique fingerprint.

Cite this

@article{58bf9a7b38ba4b0d9862477fdb2309f3,

title = "Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: The WISTERIA trial protocol",

keywords = "TITE-CRM, chemoradiation, head and neck squamous cell carcinoma, wee1 inhibitor, window of opportunity study, wisteria",

note = "Publisher Copyright: {\textcopyright} 2020 Author(s).",

year = "2020",

month = mar,

day = "16",

doi = "10.1136/bmjopen-2019-033009",

language = "English",

volume = "10",

journal = "BMJ Open",

issn = "2044-6055",

publisher = "BMJ Publishing Group",

number = "3",

}

TY - JOUR

T1 - Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer

T2 - The WISTERIA trial protocol

PY - 2020/3/16

Y1 - 2020/3/16

KW - TITE-CRM

KW - chemoradiation

KW - head and neck squamous cell carcinoma

KW - wee1 inhibitor

KW - window of opportunity study

KW - wisteria

UR - http://www.scopus.com/inward/record.url?scp=85082030646&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85082030646&partnerID=8YFLogxK

U2 - 10.1136/bmjopen-2019-033009

DO - 10.1136/bmjopen-2019-033009

M3 - Article

C2 - 32184305

AN - SCOPUS:85082030646

SN - 2044-6055

VL - 10

JO - BMJ Open

JF - BMJ Open

IS - 3

M1 - e033009

ER -

Phase I trial of WEE1 inhibition with chemotherapy and radiotherapy as adjuvant treatment, and a window of opportunity trial with cisplatin in patients with head and neck cancer: The WISTERIA trial protocol

ASJC Scopus Subject Areas

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this